These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 9286651)
1. Pharmacodynamics of intracavernously injected drugs and cavernous wall resistance. de Meyer JM; Oosterlinck W Eur Urol; 1997; 32(2):184-9. PubMed ID: 9286651 [TBL] [Abstract][Full Text] [Related]
2. [The relationship of cavernous oxygen tension with erectile dysfunction of vascular origin]. Romero-Tejada JC; Fernández Borrell A; Fernández Arjona M; Pereira Sanz I Arch Esp Urol; 1998 Nov; 51(9):919-22. PubMed ID: 9887565 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection. Becker AJ; Uckert S; Stief CG; Truss MC; Machtens S; Scheller F; Knapp WH; Hartmann U; Jonas U J Urol; 2000 Aug; 164(2):573-7. PubMed ID: 10893646 [TBL] [Abstract][Full Text] [Related]
4. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762 [TBL] [Abstract][Full Text] [Related]
5. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction]. Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770 [TBL] [Abstract][Full Text] [Related]
6. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1]. Lemaire A; Buvat J Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672 [TBL] [Abstract][Full Text] [Related]
7. Statistical evaluation of hemodynamic effects of regular use of sildenafil on the human corpora cavernosa. Natali A; Bartolini M; Lucarini S; Vignolini G; Nelli F; Menchi I Urol Int; 2009; 82(1):53-60. PubMed ID: 19172098 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a no-needle penile injector: a preliminary study evaluating tissue penetration and its hemodynamic consequences in the rat. Seyam RM; Bégin LR; Tu LM; Dion SB; Merlin SL; Brock GB Urology; 1997 Dec; 50(6):994-8. PubMed ID: 9426740 [TBL] [Abstract][Full Text] [Related]
10. Systemic and cavernous plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction. Becker AJ; Uckert S; Stief CG; Truss MC; Hartmann U; Jonas U World J Urol; 2001 Aug; 19(4):267-71. PubMed ID: 11550788 [TBL] [Abstract][Full Text] [Related]
11. The resistance index represents the corporeal pressure and not the cavernous wall resistance. de Meyer JM; Thibo P J Urol; 1997 Mar; 157(3):830-2. PubMed ID: 9072579 [TBL] [Abstract][Full Text] [Related]
12. Influence of the method of intracavernous injection on penile rigidity: a possible pharmacokinetic explanation. de Meyer JM; Oosterlinck W Urology; 1997 Feb; 49(2):248-52. PubMed ID: 9037289 [TBL] [Abstract][Full Text] [Related]
13. Intracavernous administration of SIN-1+VIP in an in vivo rabbit model for erectile function. Sazova O; Kadioğlu A; Gürkan L; Kayaarasi Z; Bross S; Manning M; Jünemann KP Int J Impot Res; 2002 Feb; 14(1):44-9. PubMed ID: 11896477 [TBL] [Abstract][Full Text] [Related]
14. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure. Mahgoub AA; El-Medany AH; Abdulatif AS Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557 [TBL] [Abstract][Full Text] [Related]
15. The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction. Vick RN; Benevides M; Patel M; Parivar K; Linnet O; Carson CC J Urol; 2002 Jun; 167(6):2618-23. PubMed ID: 11992097 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction. Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275 [TBL] [Abstract][Full Text] [Related]
18. Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions. Uckert S; Becker AJ; Ness BO; Stief CG; Scheller F; Knapp WH; Jonas U World J Urol; 2003 May; 20(6):323-6. PubMed ID: 12811490 [TBL] [Abstract][Full Text] [Related]
19. Anxiety and high plasma catecholamines do not impair pharmaco-induced erection of psychogenic erectile dysfunctional patients. Pagani E; Glina S; Puech-Leão P; Strunz CM; Chao S; Timo-Iaria C Int J Impot Res; 2003 Aug; 15(4):282-6. PubMed ID: 12934057 [TBL] [Abstract][Full Text] [Related]
20. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis. Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]